![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, January 26, 2009 3:24:57 AM
http://www.cnbc.com/id/28813740
Excerpt:
"Personalized medicine uses everything from height and weight to gene and gene-expression information to treat patients. Celera and Abbott are trying to develop molecular diagnostic products to aid in the process. The two firms recently updated their deal, which should lower Celera’s operating expenses and give the company room to launch products outside the joint venture with Abbott. So even if a merger never happens, Celera might stand on its own as a solid investment."
More here:
http://www.madmoneyrecap.com/madmoney_nightlyrecap_012309_2.htm
Excerpt: "... personalized medicine requires a lot of diagnostic tests… and that is what Celera is working on with Abbott Labs… disease detection, assessing an individuals pre-disposition to certain diseases… monitoring the progression of a disease… and choosing the right therapy…. remember President Obama loves this stuff… because it saves money on health care costs down the line..."
http://www.dnaprint.com/welcome/corporate/
http://www.dnaprint.com/welcome/pipeline/
Duane Forrester Joins INDEXR as SVP of Search • MONI • Jul 31, 2024 11:46 AM
Lingerie Fighting Championships Help Fulfill Death-Bed Promise With First Major Motion Picture • BOTY • Jul 31, 2024 9:00 AM
Kona Gold Beverage Significantly Reduces Debt from Multiple Holders • KGKG • Jul 31, 2024 9:00 AM
Avant Technologies Opens Equity Line with GHS Investments as Company Explores Expansion into Additional Technologies • AVAI • Jul 30, 2024 8:00 AM
ELEMENT79 GOLD CORP PROVIDES UPDATE ON CHACHAS COMMUNITY CHARTER AND REVENUE GENERATION, M&A ACTIVITIES • ELMGF • Jul 30, 2024 8:00 AM
INDEXR AI Merges With Moon Equity Holdings Corp. (MONI), Creating a Leading-edge Technology Company • MONI • Jul 29, 2024 9:59 AM